Show simple item record

dc.contributor.authorBoyers, Dwayne
dc.contributor.authorJia, Xueli
dc.contributor.authorCrowther, Mark
dc.contributor.authorJenkinson, David
dc.contributor.authorFraser, Cynthia
dc.contributor.authorMowatt, Graham
dc.date.accessioned2012-04-03T09:19:00Z
dc.date.available2012-04-03T09:19:00Z
dc.date.issued2011-05
dc.identifier13739205
dc.identifierbd7fe5dd-4920-45d8-849d-5d5265b9afae
dc.identifier84891671240
dc.identifier.citationBoyers , D , Jia , X , Crowther , M , Jenkinson , D , Fraser , C & Mowatt , G 2011 , ' Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP) : a single technology appraisal ' , Health Technology Assessment , vol. 15 , no. Suppl. 1 , pp. 23-32 .en
dc.identifier.issn2046-4924
dc.identifier.urihttp://hdl.handle.net/2164/2373
dc.format.extent10
dc.format.extent1245805
dc.language.isoeng
dc.relation.ispartofHealth Technology Assessmenten
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleEltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP) : a single technology appraisalen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record